Raymond James & Associates’s Avantis Emerging Markets Equity ETF AVEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$12.3M Buy
190,732
+105,243
+123% +$6.44M 0.01% 1100
2024
Q2
$5.22M Buy
85,489
+4,838
+6% +$290K ﹤0.01% 1539
2024
Q1
$4.67M Buy
80,651
+40,756
+102% +$2.29M ﹤0.01% 1632
2023
Q4
$2.25M Buy
39,895
+2,156
+6% +$116K ﹤0.01% 2033
2023
Q3
$1.99M Buy
+37,739
New +$2.05M ﹤0.01% 2025
2022
Q2
Sell
-8,998
Closed -$533K 4034
2022
Q1
$533K Sell
8,998
-676
-7% -$41.5K ﹤0.01% 3043
2021
Q4
$613K Buy
9,674
+1,879
+24% +$121K ﹤0.01% 2940
2021
Q3
$503K Sell
7,795
-3,987
-34% -$264K ﹤0.01% 3057
2021
Q2
$819K Sell
11,782
-1,093
-8% -$74.3K ﹤0.01% 2727
2021
Q1
$846K Buy
+12,875
New +$850K ﹤0.01% 2615

Other funds holding AVEM

Raymond James & Associates's AVEM Position: Q3 2024 in Review

Raymond James & Associates increased its Avantis Emerging Markets Equity ETF (AVEM) stake by 123% in Q3 2024, buying an estimated $6.44M and bringing the position to 190,732 shares worth $12.3M. The position accounts for 0.01% of the portfolio, ranked #1100.

Raymond James & Associates first reported a position in AVEM in Q1 2021 and has held it in 10 quarters since. 449 funds tracked by Wall St. Rank hold AVEM as of Q3 2024.

  • Raymond James & Associates held 190,732 shares of Avantis Emerging Markets Equity ETF worth $12.3M as of Q3 2024.
  • Raymond James & Associates bought 105,243 Avantis Emerging Markets Equity ETF shares in Q3 2024, an estimated $6.44M.
  • Avantis Emerging Markets Equity ETF made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1100 holding.
  • Raymond James & Associates first reported a position in Avantis Emerging Markets Equity ETF in Q1 2021 and has held it in 10 quarters since.
  • 449 funds tracked by Wall St. Rank held Avantis Emerging Markets Equity ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.